If you are on the maximum dose of semaglutide (2.4 mg for Wegovy) or tirzepatide (15 mg for Mounjaro), your peak drug levels are already near the top of the therapeutic range
Both the demand and supply of these drugs have exceeded all expectations and the momentum driving the market suggests they are highly likely to become a permanent feature of the food landscape. Manufacturers such as Nestle have responded, debuting its Vital Pursuit brand specifically designed to support GLP-1 consumer diets
What This Means for You If you're on a GLP-1 medication and you're feeling flat you're not imagining it
Compounded versions haven't been tested in those trials, haven't demonstrated comparable safety profiles across different patient groups, and lack proven batch-to-batch consistency, making them unreliable for reproducible results
But patients will need careful monitoring to make sure the weight they lose is mostly fat, not muscle
Peptide12 offers every credible GLP-1 path compounded semaglutide and tirzepatide for cash-pay flexibility, plus FDA-approved branded pens (Wegovy, Ozempic, Zepbound, Mounjaro) when your insurance covers them